Search

Dana Silva is the update co-author of chapter 15, “Litigation.” She is an associate at Saul Ewing LLP in Century City. Her current practice focuses primarily on commercial litigation, but she also has years of experience representing employers in all types of employment litigation.

​On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...